10-Q: Wenyuan Group Reports Q3 2025 Loss, Zero Revenue
Quarterly Report
Wenyuan Group Corp. reported a net loss of $74,823 for Q3 2025 and zero revenue for the nine months ended September 30, 2025, raising substantial doubt about its ability to continue as a going concern.
Summary
- Net loss for the three months ended September 30, 2025, was $74,823, an improvement from $84,985 in the prior year period.
- Net loss for the nine months ended September 30, 2025, was $239,602, significantly lower than $882,004 in the prior year period.
- Revenue for the three months ended September 30, 2025, was $11,263, a substantial decrease from $67,968 in the prior year period.
- No revenue was generated for the nine months ended September 30, 2025, compared to $67,968 in the prior year period, primarily due to a decline in market demand for cultural and health products.
- The company has an accumulated deficit of $21,465,393 as of September 30, 2025, and a working capital deficit of $305,645.
- Cash and cash equivalents decreased to $7,608 as of September 30, 2025, from $27,208 at December 31, 2024.
- The company's subsidiary, Hangzhou Wenyuan, was ruled to pay approximately $264,071 (RMB 1,900,000) as a guarantor in a legal proceeding, with the office suite involved having undergone two unsuccessful judicial auctions.
- Management concluded that disclosure controls and procedures were not effective as of September 30, 2025.
Sentiment
Score: 1
Explanation: The company is in severe financial distress, evidenced by zero revenue for the nine-month period, a significant accumulated deficit, a "going concern" warning, and critically low cash reserves. Compounding these issues are ineffective disclosure controls and a substantial legal liability.
Positives
- Net loss for the three months ended September 30, 2025, decreased to $74,823 from $84,985 in the same period last year.
- Net loss for the nine months ended September 30, 2025, significantly decreased to $239,602 from $882,004 in the same period last year, primarily due to reduced share-based compensation expenses.
- Net cash used in operating activities decreased to $133,133 for the nine months ended September 30, 2025, from $325,521 in the prior year period.
Negatives
- The company generated zero revenue for the nine months ended September 30, 2025, a 100% decline from $67,968 in the prior year period.
- Revenue for the three months ended September 30, 2025, decreased by 83.4% to $11,263 from $67,968 in the prior year period.
- The company has an accumulated deficit of $21,465,393 as of September 30, 2025.
- A working capital deficit increased to $305,645 as of September 30, 2025, from $184,093 at December 31, 2024.
- Cash and cash equivalents significantly declined to $7,608 as of September 30, 2025, from $27,208 at December 31, 2024.
- Total current liabilities increased to $375,348 as of September 30, 2025, from $307,926 at December 31, 2024.
- Stockholders' equity shifted to a deficit of $(19,836) as of September 30, 2025, from positive equity of $107,647 at December 31, 2024.
- Disclosure controls and procedures were deemed not effective as of September 30, 2025.
Risks
- Substantial doubt exists about the company's ability to continue as a going concern due to recurring net losses, accumulated deficit, and dependence on future profitable operations and additional financing.
- The company faces a legal judgment requiring its subsidiary, Hangzhou Wenyuan, to pay approximately $264,071 (RMB 1,900,000) as a guarantor for a third-party's debt, with the underlying asset (office suite) having failed two judicial auctions.
- The company's disclosure controls and procedures were not effective, indicating potential weaknesses in financial reporting and information dissemination.
- Complete cessation of revenue from offline product sales for the nine months ended September 30, 2025, highlights significant market demand challenges for its current product offerings.
- Dependence on raising funds from equity and/or debt securities, with no assurance that such funds will be available on acceptable terms or at all.
Future Outlook
Management anticipates a gradual recovery in the sales of cultural and health products beginning in September 2025. The company is actively exploring additional profitable business segments to support future growth. However, there can be no assurance that plans to improve profitability, generate sufficient cash flow, or obtain additional financing will be successful.
Management Comments
- "Management anticipates a gradual recovery in the sales of cultural and health products beginning in September 2025."
- "The Company is actively exploring additional profitable business segments to support future growth."
- "Managements plan to alleviate the substantial doubt about the Companys ability to continue as a going concern include attempting to improve its business profitability, its ability to generate sufficient cash flow from its operations to meet its operating needs on a timely basis, obtain additional working capital funds from the majority shareholder and the President of the Company to eliminate inefficiencies in order to meet its anticipated cash requirements."
Industry Context
The filing indicates a significant decline in market demand for the company's cultural and health products, leading to a complete cessation of revenue from offline product sales for the nine months ended September 30, 2025. This suggests the company is struggling to adapt to or compete within its current market segment, necessitating a search for new profitable business segments. The shift away from aquaculture products in 2024 also points to challenges in previous ventures, highlighting a broader difficulty in establishing a sustainable business model within its operating environment.
Comparison to Industry Standards
- The company's complete lack of revenue for the nine months ended September 30, 2025, and a substantial accumulated deficit of over $21 million, are significantly below industry standards for a viable operating company.
- The "going concern" warning indicates severe financial distress, a condition typically associated with companies facing imminent risk of bankruptcy or cessation of operations, unlike healthy industry peers.
- The ineffectiveness of disclosure controls and procedures suggests a lack of robust internal governance, which is a critical standard for publicly traded companies.
- The legal liability of $264,071 as a guarantor, coupled with unsuccessful auctions of the underlying asset, points to poor risk management and due diligence compared to industry best practices.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Disclosure Controls and Procedures | Management concluded that disclosure controls and procedures were not effective as of September 30, 2025. | 2025-09-30 | Indicates a material weakness in the company's ability to timely record, process, summarize, and report financial information, posing significant risks to investors and regulatory compliance. |
Legal Proceedings
- Hangzhou Wenyuan, a subsidiary, was ruled by The Shangcheng District People's Court of Hangzhou City, Zhejiang Province, China, on October 22, 2024, to pay a creditor approximately $264,071 (RMB 1,900,000). This liability stems from Hangzhou Wenyuan acting as a guarantor for a third-party seller's debt associated with an office suite purchase.
- The office suite, which was the subject of the guarantee, has been subjected to two unsuccessful online judicial auctions due to the defendant's failure to comply with court orders.
- Hangzhou Wenyuan is currently preparing legal materials to initiate lawsuits against both the creditor and the seller.
- The company is also preparing to file a lawsuit in Nevada State to seek the recovery of shares previously issued as part of the office suite purchase consideration.
Related Party Transactions
- Shareholder loan payable to the President of $5,575 as of September 30, 2025, which is unsecured, non-interest-bearing, and due on demand.
- Amount owed to the President's wife totaled $2,065 as of September 30, 2025, which is unsecured, non-interest-bearing, and due on demand.
- Employee compensation expenses of $37,893 were recognized for related parties (President, his wife, and daughter) during the nine months ended September 30, 2025.
- Compensation payable to these related parties totaled $24,167 as of September 30, 2025.
- Amount payable to Hangzhou Wenyuan Yiyun Media Co., Ltd. (controlled by the President's daughter) totaled $2,572 as of September 30, 2025, for inventory purchases.
Stakeholder Impact
- Shareholders: Significant negative impact due to zero revenue, accumulated deficit, going concern warning, ineffective controls, and potential dilution from ongoing capital raises at low share prices. The legal proceedings also pose a risk to company assets.
- Creditors: The company's precarious financial position and going concern warning increase the risk of default. The legal judgment against a subsidiary adds to liabilities.
- Employees: The company's financial instability and lack of revenue could impact job security and future compensation.
- Customers: The cessation of product sales indicates a disruption in service or product availability.
Next Steps
- Management intends to raise funds from the issuance of equity and/or debt securities.
- Management plans to improve business profitability and generate sufficient cash flow from operations.
- Management is actively exploring additional profitable business segments.
- Hangzhou Wenyuan is preparing legal materials to initiate lawsuits against the creditor and the seller related to the office suite guarantee.
- The company is preparing to file a lawsuit in Nevada State to seek recovery of shares previously issued as part of the office suite purchase consideration.
Key Dates
| Date | Description |
|---|---|
| 1980-03-31 | Company originally incorporated as Expertelligence, Inc. in California. |
| 2005-11-17 | Company reincorporated in Nevada. |
| 2016-01-21 | Change of control occurred; Harold Minsky resigned, G. Reed Petersen elected officer. |
| 2016-04-05 | Board approval for name change to Wenyuan Group Corp. and company affected a 1 for 750 share reverse split. |
| 2016-11-29 | G. Reed Peterson sold shares to Longwen Group Corporation (Cayman Island); Mr. Petersen resigned, Mr. Xizhen Ye appointed officer/director. |
| 2017-01-23 | Company amended Articles of Incorporation to change name to Longwen Group Corp. with trading symbol LWLW. |
| 2021-06-09 | Anthony Lombardo filed an Application for Appointment of Custodian. |
| 2021-06-24 | Hearing held, Lombardo named temporary custodian. |
| 2021-09-01 | Deanna Johnson appointed Joseph Passalaqua as CEO, CFO, Secretary and resigned. |
| 2021-10-25 | Mr. Xizhen Ye and Longwen Group Corporation filed a Motion to Dissolve Custodianship. |
| 2022-01-12 | Mr. Ye reinstated as officer and director per Settlement Agreement. |
| 2022-02-09 | Joseph Passalaqua transferred 65,000,000 common stocks to Mr. Ye. |
| 2022-02-17 | Eighth Judicial District Court formally dismissed Lombardo's custodianship. |
| 2022-02-23 | Company entered Acquisition Agreement to acquire 100% of Hangzhou Wenyuan Enterprise Management Co., Ltd. for $1,000. |
| 2022-09-28 | Company consummated office suite purchase agreement with a third party, issuing 2,651,780 common shares. |
| 2022-10-11 | Company and Hangzhou Wenyuan entered Acquisition Agreement to acquire 100% of Hangzhou Wenyuan Art and Culture Co., Ltd. for RMB 1,000 (approx. $141). |
| 2022-11-07 | Board adopted the 2022 Equity Incentive Plan. |
| 2023-03-03 | Hangzhou Wenyuan established Huzhou Wohong Fishery Co., Ltd. (HWF). |
| 2023-12-31 | Balance sheet date for prior fiscal year. |
| 2024-01-01 | Company adopted ASU 2023-07, Segment Reporting, retrospectively. |
| 2024-02-18 | Company entered debt settlement agreement, issuing 279,490 common stocks for $83,847 debt. |
| 2024-02-27 | Hangzhou Longwen Enterprise Management Co., Ltd changed its name to Hangzhou Wenyuan Enterprise Management Co., Ltd. |
| 2024-03-27 | HWF entered agreement to sell certain assets and liabilities; HWF identified as discontinued operations. |
| 2024-03-31 | Sale of HWF assets and liabilities closed. |
| 2024-04-03 | Common stocks issued for cash proceeds received from investors at end of March 2024. |
| 2024-04-10 | Hangzhou Yusu was renamed to Hangzhou Wenyuan Art and Culture Co., Ltd (HWAC). |
| 2024-04-15 | Annual Report on Form 10-K for year ended December 31, 2024, filed. |
| 2024-10-22 | Shangcheng District People's Court of Hangzhou City, Zhejiang Province, China, ruled that Hangzhou Wenyuan is required to pay a creditor approximately $264,071 (RMB 1,900,000). |
| 2024-12-15 | Effective date for ASU 2023-09 for fiscal years beginning after this date. |
| 2025-01-01 | Effective date for ASU 2023-09 for the company. |
| 2025-01-21 | Company's name officially changed to Wenyuan Group Corp. with OTC Markets, and stock symbol changed to WYGC. |
| 2025-09-30 | End of current reporting period. |
| 2025-10-01 | Start of period for subsequent event of common stock sales. |
| 2025-10-31 | End of period for subsequent event of common stock sales. |
| 2025-11-14 | Date of filing of this 10-Q report and common stock outstanding count. |
| 2026-12-15 | Effective date for ASU No. 2024-03 for fiscal years beginning after this date. |
| 2027-12-15 | Effective date for ASU No. 2024-03 for interim periods within fiscal years beginning after this date. |
Recommendation
strong sellThe company exhibits severe financial distress with zero revenue for the nine-month period, a substantial accumulated deficit, and a "going concern" warning. Cash reserves are critically low, and working capital is deeply negative. Furthermore, disclosure controls are ineffective, and the company faces a significant legal liability. These factors collectively indicate a high risk of business failure and significant downside for investors.
Keywords
Wenyuan Group Corp, WYGC, 10-Q, Quarterly Report, Financial Results, Net Loss, Revenue Decline, Going Concern, Legal Proceedings, Shareholder Loan, Related Party Transactions, Equity Incentive Plan, China Operations, Cultural and Health Products, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.